Dose escalation for anti-TNF therapies has been well incorporated into clinical practice for children and adults with waning of clinical efficacy of anti-TNF therapy over time. In the ACCENT I 54 ...

"Lymphoma is the third most common cancer in children under 15 years of age and the most common cancer in adolescents and young adults age 15-35, accounting for one out of every four cancers in that ...

Provided by PR Newswire May 28, 2025, 6:12:00 AM Unleashed Brands Foundation Pledges $1 Million to Advance The Leukemia & Lymphoma Society's Work in Children's Blood Cancers ...

RYE BROOK, N.Y., Nov. 14, 2024 /PRNewswire/ -- Children with Down syndrome are up to 150 times more likely to develop acute myeloid leukemia before age 5 and yet very little research has been done ...

The center — the first in the world dedicated specifically to the research, care and treatment of children with lymphoma — was created through a gift of $10 million to Texas Children’s Hospital.

Using the SEER-Medicaid data, we identified children and AYAs (aged 0-39 years) newly diagnosed with lymphoma between 2007-2013 in 12 states that were linked to the administrative Medicaid data.

Leukemia and Lymphoma Society describe Non-Hodgkin’s Lymphoma as a type of cancer that begins in the lymphatic system, which is part of the body’s germ-fighting immune system.

Background: Burkitt lymphoma is an aggressive non-Hodgkin lymphoma originating from mature B cells. This meta-analysis aims to assess the efficacy and safety of rituximab in treating Burkitt lymphoma ...

Excellent survival for advanced (stages II with high lactate dehydrogenase, III, and IV) pediatric mature B-cell non-Hodgkin lymphoma (MB-NHL) has been achieved with intensive regimens, but adoption ...